Clinical Trials Browser

Interventional × Ovarian Neoplasms × ixabepilone × Clear all

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Ovarian Neoplasms, Breast Neoplasms, Male

NCT00030706 2018-09-28

Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Phase 2 Completed

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00070096 2013-06-24

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Phase 2 Completed

29 enrolled

CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00030108 2012-03-15

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Phase 1 Completed

30 enrolled

CNSGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmSarcoma

Familial ependymoma, Ovarian Germ Cell Cancer, Astrocytoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Oligodendroglioma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Eosinophilic, Acute, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Optic Nerve Glioma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

BMS-247550

Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy